ICADE SANTE (EPA:ICSAA) APPROBATION OF THE CHANGE OF ICADE SANTÉ CORPORATE FORM AND OTHER AMENDMENTS TO THE BY-LAWS

Transparency directive : regulatory news

27/07/2021 16:15

PRESS RELEASE
Paris, July 27, 2021, 16h15

  CONSULTATION OF THE NOTEHOLDERS IN THE CONTEXT OF THE CONTEMPLATED INITIAL
  PUBLIC OFFERING OF ICADE SANTÉ. APPROBATION OF THE CHANGE OF ICADE SANTÉ
             CORPORATE FORM AND OTHER AMENDMENTS TO THE BY-LAWS.

In the context of the contemplated initial public offering of Icade Santé on
the regulated market of Euronext Paris by the end of 2021, subject to market
conditions, announced on 7 June 2021 by Icade SA, the majority shareholder of
Icade Santé holding 58.30% of its share capital, the holders of the EUR
500,000,000 notes issued on 4 November 2019 by Icade Santé bearing interest at
a rate of 0.875 per cent and maturing on 4 November 2029 - ISIN : FR0013457967
(the "Notes") convened today in a general meeting on first convocation(1) have
approved :

(i) the change of Icade Santé's corporate form from a société par actions
    simplifiée to a société anonyme à conseil d'administration ;

(ii) the extension of the current corporate purpose of Icade Santé (which is
     currently limited to France), to international activities; and

(iii) other amendments to the by-laws.

The change of corporate form and the abovementioned amendments to the by-laws
would enter into force from the date of approval by the French Autorité des
Marchés Financiers of the prospectus relating to the admission of Icade
Santé's shares to trading on the regulated market of Euronext Paris.

Icade Santé invites the holders of the Notes to consult the section dedicated
to the general meeting of the holders of Notes on the company's website
(www.icade-sante.fr).

                                  Disclaimer

This press release does not contain and does not constitute an offer to sell
securities, or an invitation or the solicitation to invest in securities in
France, in the United States or in any other jurisdiction.

                              ABOUT ICADE SANTÉ

With a portfolio worth EUR5.5 billion excluding duties (100%) as of 30 June
2021, Icade Santé is the leading investor in private healthcare facilities in
France. A 58.3% owned subsidiary of the Icade Group, Icade Santé draws on its
proven expertise, its long-term shareholders as well as its extensive knowledge
of the real estate value chain. Since 2018, Icade Santé has pursued a strategy
of diversification into the nursing home segment.

Icade Santé is rated BBB+ with a stable outlook by rating agency S&P.

The text of this press release as well as the consolidated financial statements
prepared in accordance with IFRS are available on the Icade Santé website:
https://icade-sante.fr

CONTACTS

Yoann Nguyen
Head of Investors Relations
+33(0)6 31 58 97 31
yoann.nguyen@icade.fr

Etienne Maurer
Deputy CFO
+33(0)1 41 57 79 02
etienne.maurer@icade.fr

(1) See Icade Santé's press release of July 9, 2021.

ICADE SANTE's latest news

13/03/2023 20:15

ICADE SANTE (EPA:ICSAA) APPROBATION OF THE CHANGE OF ICADE SANTÉ CORPORATE FORM AND OTHER AMENDMENTS TO THE BY-LAWS

Transparency directive : regulatory news

ICADE SANTE's latest news

Other stories